(Q44563581)

English

Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimisation of substituted 2,4-bis anilino pyrimidines

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimisation of substituted 2,4-bis anilino pyrimidines (English)

1 reference

Europe PubMed Central

4 December 2017

Rebecca Ellston

2

1 reference

Europe PubMed Central

4 December 2017

author name string

Gloria A Breault

1

1 reference

Europe PubMed Central

4 December 2017

Stephen Green

3

1 reference

Europe PubMed Central

4 December 2017

S Russell James

4

1 reference

Europe PubMed Central

4 December 2017

Philip J Jewsbury

5

1 reference

Europe PubMed Central

4 December 2017

Catherine J Midgley

6

1 reference

Europe PubMed Central

4 December 2017

Richard A Pauptit

7

1 reference

Europe PubMed Central

4 December 2017

Claire A Minshull

8

1 reference

Europe PubMed Central

4 December 2017

Julie A Tucker

9

1 reference

Europe PubMed Central

4 December 2017

J Elizabeth Pease

10

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

4 December 2017

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

4 December 2017

13

1 reference

Europe PubMed Central

4 December 2017

2961-2966

1 reference

Europe PubMed Central

4 December 2017

18

1 reference

Europe PubMed Central

4 December 2017

Cancer cell cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclin D1 in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The INK4 family of cell cycle inhibitors in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Rb/E2F pathway and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of selective inhibitors of cyclin dependent kinase 4

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cinnamaldehydes inhibit cyclin dependent kinase 4/cyclin D1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclin-Dependent Kinase Inhibition by New C-2 Alkynylated Purine Derivatives and Molecular Structure of a CDK2−Inhibitor Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

An extensively modified version of MolScript that includes greatly enhanced coloring capabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900203-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-894X(03)00203-8

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44563581&oldid=2028151032"